EUVIMEDEUVIMED entdecken
QuerschnittstudieOpen Access · CC BY 4.0

The IgA Vasculitis Study: the evolution of a cross-sectional cohort into a trial-ready cohort

Chloe E C Williams iD, Julien Marro iD, Andrew J Chetwynd iD, Joseph Brown iD, Nikolaos Skoutelis iD, Silothabo Dliso iD, Catherine McBurney iD, Louise Oni iD

Rheumatology Advances in Practice · 13.09.2025 · 9 (4)

DOI: 10.1093/rap/rkaf099 ↗

Kurz gefasst

Querschnittstudie in der Zeitschrift Rheumatology Advances in Practice, online erschienen am 21.08.2025. Verfasst von Chloe E C Williams und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nephrology, Royal Liverpool and Broadgreen University Hospital Trusts, Liverpool, UK. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Kidney Research UK, National Health Service, NIHR or Department of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

The aim of this report is to describe a single-centre cohort study and its evolutionary stages into a trial-ready cohort with the vision of stopping kidney failure secondary to IgA vasculitis (IgAV).

Methods

The IgA Vasculitis Study was established as a single-centre, cross-sectional cohort study recruiting children with a clinical diagnosis of IgAV and has evolved into a trial-ready framework. Sociodemographic and clinical data, as well as corresponding biosamples, were collected longitudinally and the natural history of the first 100 recruits is provided.

Results

The IgA Vasculitis Study commenced in June 2019. The first 100 children recruited to the study had a mean age of 7.3 years (s.d. 3.7) and a male:female ratio of 1.5:1. At presentation, all children had a lower limb–predominant rash, 76% had musculoskeletal involvement, 43% gastrointestinal involvement and 23% met the definition of nephritis. Most children (54%) were discharged after 6 months, however, 17% required paediatric nephrology input. The mean timing of onset for nephritis was 25.5 days (s.d. 22.9) following disease presentation (range 0.0–101 days). Fourteen children with IgAV nephritis (IgAV-N) received immunosuppression. Children with an older age, residing in more affluent areas, with gastrointestinal involvement or a positive urine dipstick (for proteinuria and/or haematuria) at presentation had greater odds of developing nephritis. Children with IgAV-N had statistically significantly more hospital visits and unplanned hospital admissions (P < 0.001).

Conclusion

Nephritis remains a serious consequence of IgAV with little evidence to guide management. This report outlines an exemplar study to advance the field towards better interventions.

Schlagwörter

Stichwörter der Autor:innen

Henoch–Schönlein purpurachildrenkidneynephritispaediatric

Autor:innen und Institutionen

  • Department of Nephrology, Royal Liverpool and Broadgreen University Hospital Trusts, Liverpool, UK.
  • Department of Women's and Children's Health, Institute of Life Course and Medical Sciences, University of Liverpool, Liverpool, UK.
  • Centre for Proteome Research, Department of Biochemistry, Cell and Systems Biology, Institute of Systems, Molecular and Integrative Biology, University of Liverpool, Liverpool, UK.
  • Department of Paediatric Nephrology, Alder Hey Children's NHS Foundation Trust Hospital, Liverpool, UK.
  • National Institute for Health and Care Research Alder Hey Clinical Research Facility, Clinical Research Division, Alder Hey Children's NHS Foundation Trust, Liverpool, UK.
  • Department of Paediatric Nephrology, Great Ormond Street Hospital for Children, London, UK.

ORCID-Profile: Chloe E C Williams, Julien Marro, Andrew J Chetwynd, Joseph Brown, Nikolaos Skoutelis, Silothabo Dliso, Catherine McBurney, Louise Oni

Förderung

  • Kidney Research UK
  • National Health Service, NIHR or Department of Health

Zitieren

APA

Williams, C. E. C., Marro, J., Chetwynd, A. J., Brown, J., Skoutelis, N., Dliso, S., McBurney, C., & Oni, L. (2025). The IgA Vasculitis Study: the evolution of a cross-sectional cohort into a trial-ready cohort. Rheumatology Advances in Practice, 9(4). https://doi.org/10.1093/rap/rkaf099

Vancouver

Williams CEC, Marro J, Chetwynd AJ, Brown J, Skoutelis N, Dliso S, et al. The IgA Vasculitis Study: the evolution of a cross-sectional cohort into a trial-ready cohort. Rheumatology Advances in Practice. 2025;9(4). doi:10.1093/rap/rkaf099

BibTeX
@article{Williams2025,
  author = {Williams, Chloe E C and Marro, Julien and Chetwynd, Andrew J and Brown, Joseph and Skoutelis, Nikolaos and Dliso, Silothabo and McBurney, Catherine and Oni, Louise},
  title = {The IgA Vasculitis Study: the evolution of a cross-sectional cohort into a trial-ready cohort},
  journal = {Rheumatology Advances in Practice},
  year = {2025},
  volume = {9},
  number = {4},
  doi = {10.1093/rap/rkaf099}
}
Kostenlos starten →